EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitNetzwerk-MetaanalyseOpen Access

Tegoprazan-Amoxicillin Dual Therapy Versus Bismuth Quadruple Therapy Versus Tegoprazan-Based Quadruple Therapy for Helicobacter pylori Eradication: A Network Meta-Analysis

Roopa Velaga, Kinan Obeidat, Anastasia Postoev, Nawabzada Nadir Babar, Rahman Hameed Mohammed Abdul, Sonalben Chaudhary, Calvin R Wei, Danish Allahwala

Cureus · 13.04.2026

DOI: 10.7759/cureus.107000 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 13.04.2026. Verfasst von Roopa Velaga und 7 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Jagadguru Jayadeva Murugarajendra Medical College, Davangere, IND. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

bismuth quadruple therapyhelicobacter pylorinetwork meta-analysispotassium-competitive acid blockertegoprazan

Autor:innen und Institutionen

  • Internal Medicine, Jagadguru Jayadeva Murugarajendra Medical College, Davangere, IND.
  • Internal Medicine, University of Texas Medical Branch at Galveston, Galveston, USA.
  • Internal Medicine, Caribbean Medical University, Willemstad, CUW.
  • Internal Medicine, Combined Medical Hospital Lahore Medical College and Institute of Dentistry, Lahore, PAK.
  • Gastroenterology and Hepatology, Royal Derby Hospital, Stoke-on-Trent, GBR.
  • Internal Medicine, Zydus Sitapur Hospital, Sitapur, IND.

Zitieren

APA

Velaga, R., Obeidat, K., Postoev, A., Babar, N. N., Mohammed Abdul, R. H., Chaudhary, S., Wei, C. R., & Allahwala, D. (2026). Tegoprazan-Amoxicillin Dual Therapy Versus Bismuth Quadruple Therapy Versus Tegoprazan-Based Quadruple Therapy for Helicobacter pylori Eradication: A Network Meta-Analysis. Cureus. https://doi.org/10.7759/cureus.107000

Vancouver

Velaga R, Obeidat K, Postoev A, Babar NN, Mohammed Abdul RH, Chaudhary S, et al. Tegoprazan-Amoxicillin Dual Therapy Versus Bismuth Quadruple Therapy Versus Tegoprazan-Based Quadruple Therapy for Helicobacter pylori Eradication: A Network Meta-Analysis. Cureus. 2026. doi:10.7759/cureus.107000

BibTeX
@article{Velaga2026,
  author = {Velaga, Roopa and Obeidat, Kinan and Postoev, Anastasia and Babar, Nawabzada Nadir and Mohammed Abdul, Rahman Hameed and Chaudhary, Sonalben and Wei, Calvin R and Allahwala, Danish},
  title = {Tegoprazan-Amoxicillin Dual Therapy Versus Bismuth Quadruple Therapy Versus Tegoprazan-Based Quadruple Therapy for Helicobacter pylori Eradication: A Network Meta-Analysis},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.107000}
}
Kostenlos starten →